Share: Facebook Twitter LinkedIn
Activity Provided By:

Primary Care Education Consortium

Identification and Management of Insomnia in Alzheimer's Disease

Access Activity

Overview / Abstract:

LEARNING OBJECTIVES
After reading the review article on insomnia
in patients with Alzheimer's disease (AD),
participants should be able to:
• Describe the association of insomnia
with AD.
• Characterize the burden of insomnia in AD
on patients and their family/caregivers.
• Prescribe medication for insomnia in
patients with AD based on existing evidence
and current recommendations.
TARGET AUDIENCE
Family physicians and clinicians who wish
to gain increased knowledge and greater
competency regarding primary care management
of insomnia in patients with AD.

Alzheimer's disease (AD) is the most common cause of
dementia, affecting an estimated 5.7 million Americans;
nearly two-thirds are women. The vast majority of people
with AD are aged ≥65 years. After age 85 years, 34% of people
have AD or related dementia. Most people with AD survive
an average of 4 to 8 years following diagnosis, although some
live as long as 20 years. AD is the only top 10 cause of death
that cannot be prevented or cured. In 2017, AD was the 15th
leading cause of disability-adjusted life years worldwide.
Beyond progressive cognitive impairment, people with
AD are at increased risk of neuropsychiatric symptoms such
as delusions and hallucinations, depressive symptoms, wandering,
anxiety, disturbances in diurnal rhythm, and agitation
with or without aggression. Apathy is more common in
those with AD onset before age 65 years. Neuropsychiatric
symptoms, particularly delusions, may be associated with a
more severe course of AD.

PHYSICIANS: To receive CME credit,
please read the journal article and, on
completion, go to www.pceconsortium.
org/insomnia to complete the online
post-test and receive your certificate of
credit.
PHYSICIAN ASSISTANTS: AAPA accepts
certificates of participation of educational
activities certified for AMA PRA Category
1 Credit™ from organizations accredited
by ACCME or a recognized state medical
society.

Expiration

Sep 30, 2020

Discipline(s)

Nurse Practitioner , Physician CME, Physician Assistant CME

Format

Journal, Monograph, Online

Credits / Hours

1

Accreditation

ACCME, AMA PRA Category 1

Presenters / Authors / Faculty

that cannot be prevented or cured.1 In 2017, AD was the 15th
leading cause of disability-adjusted life years worldwide.3
Beyond progressive cognitive impairment, people with
AD are at increased risk of neuropsychiatric symptoms such
as delusions and hallucinations, depressive symptoms, wandering,
anxiety, disturbances in diurnal rhythm, and agitation
with or without aggression.4,5 Apathy is more common in
those with AD onset before age 65 years.4 Neuropsychiatric
symptoms, particularly delusions, may be associated with a
more severe course of AD.6

Sponsors / Supporters / Grant Providers

This activity is sponsored by Primary Care Education Consortium.
This article is supported by an educational
grant from Merck & Co, Inc..

Keywords / Search Terms

Primary Care Education Consortium insomnia, Alzheimer's Disease, AD, dementia, cognitive Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map